Sookjin Lee

Chief Business Officer (CBO) | Ph.D.

A business expert leading innovation in precision medicine and genomics for 20 years. Accelerating the commercialization of innovative technologies with academic expertise and market insight.

Achondroplasia in Children: From the FGFR3 Mutation to Voxzogo, the First Targeted Therapy2026. 07. 24
Solving Undiagnosed Cases with Long-Read Sequencing (Part 1): Finding the Missing Variant in Autosomal Recessive Disease2026. 07. 22
ICD-10 Metabolic Encephalopathy: What the Code G93.41 Means2026. 07. 14
Reproductive Genetic Carrier Screening (RGCS): When and Who to Recommend It To — A Clinical Guide from 5 Year Outcome Data2026. 07. 02
Genomic Newborn Screening (gNBS) Caught 8 Cases Conventional Tests Missed — A 9,992-Newborn WGS Cohort From Qingdao2026. 06. 27
[Clinical Insight] “Rarely Diagnosed, Not Rare” – An Interview with Dr. Dmytro Tokariev2026. 06. 26